米国の徐放性コーティング市場規模、シェア、動向分析レポート：基材別、用途別、ポリマー材料別、セグメント別予測、2025～2033年

米国の徐放性コーティング市場概要

米国の徐放性コーティング市場規模は2024年に1億6,940万米ドルと推定され、2033年には3億540万米ドルに達すると予測され、2025～2033年のCAGRは6.2%で成長すると予測されます。市場の成長は、特に糖尿病、心血管疾患、神経疾患などの慢性疾患の治療において、治療効果と患者のアドヒアランスを向上させる先進的ドラッグデリバリーシステムに対する需要の高まりが主因となっています。

新興医薬品メーカーとジェネリック医薬品メーカーの両方からの多額の投資に支えられた新興諸国の強固な医薬品研究開発エコシステムは、洗練されたコーティング技術の継続的な開発を促進しています。同市場は、個別化医療や精密医療の普及、1日1回投与製剤や長時間作用型製剤の需要の増加、ブランド品のライフサイクル管理やジェネリック医薬品の差別化における徐放性技術の利用拡大などにより、大きな成長機会をもたらしています。生分解性ポリマー、植物由来ポリマー、スマートポリマーの開発など、ポリマー科学の進歩はドラッグデリバリーの革新に新たな道を開いています。

市場は成熟しているもの、高い製剤開発コスト、複雑な規制遵守要件、多様な患者集団で一貫した薬剤放出を実現する技術的困難などの課題に直面しています。また、特殊な製造インフラと熟練した専門知識が必要であるため、徐放性製品を市場に投入するための資金負担も大きくなります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の徐放性コーティング市場の変数、動向、範囲

• 市場の系統/補助市場の展望
• 産業バリューチェーン分析
  • 流通チャネル分析
  • 製造業の動向/技術の進歩
  • 原料の動向
• 価格動向分析、2018～2033年
  • 価格に影響を与える要因
• 規制の枠組み
  • アナリストの視点
  • 規制と基準
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 産業の機会
  • 産業の課題
• ビジネス環境ツール分析：米国の徐放性コーティング市場
  • ポーターのファイブフォース分析
  • PESTLE分析

第4章 米国の徐放性コーティング市場：用途別、推定・動向分析

• 主要ポイント
• 用途変動分析と市場シェア、2024年と2033年
  • 米国の徐放性コーティング市場（用途別）、2021～2033年
• 体外
• 体内

第5章 米国の徐放性コーティング市場：基材別、推定・動向分析

• 主要ポイント
• 基材変動分析と市場シェア、2024年と2033年
• 米国の徐放性コーティング市場（基材別）、2021～2033年
• 錠剤
• カプセル
• 丸薬

第6章 米国の徐放性コーティング市場：ポリマー材料別、推定・動向分析

• 主要ポイント
• ポリマー材料変動分析と市場シェア、2024年と2033年
• 米国の徐放性コーティング市場（ポリマー材料別）、2021～2033年
• エチルとメチルセルロース
• ポリビニルとセルロースアセテート
• メタクリル酸
• ペグ
• その他

第7章 競合情勢

• 主要参入企業、最近の動向、産業への影響
• 競合の分類
• 企業の市況分析
• 企業ヒートマップ分析
• 戦略マッピング、2024年
• 企業リスト
  • BASF SE
  • Evonik
  • Colorcon
  • Coating Place, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Novartis AG
  • AstraZeneca
  • GlaxoSmithKline plc
  • AbbVie Inc.

List of Tables

• Table 1 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Application, 2018 - 2033 (USD Million) (Kilotons)
• Table 2 U.S. Sustained Release Coatings Market Estimates And Forecasts, by In Vitro, 2018 - 2033 (USD Million) (Kilotons)
• Table 3 U.S. Sustained Release Coatings Market Estimates And Forecasts, by In Vivo, 2018 - 2033 (USD Million) (Kilotons)
• Table 4 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Polymer Material, 2018 - 2033 (USD Million) (Kilotons)
• Table 5 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Ethyl & Methyl Cellulose, 2018 - 2033 (USD Million) (Kilotons)
• Table 6 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Polyvinyl & Cellulose Acetate, 2018 - 2033 (USD Million) (Kilotons)
• Table 7 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Methacrylic Acid, 2018 - 2033 (USD Million) (Kilotons)
• Table 8 U.S. Sustained Release Coatings Market Estimates And Forecasts, by PEG, 2018 - 2033 (USD Million) (Kilotons)
• Table 9 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Others, 2018 - 2033 (USD Million) (Kilotons)
• Table 10 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Substrate, 2018 - 2033 (USD Million) (Kilotons)
• Table 11 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Tablets, 2018 - 2033 (USD Million) (Kilotons)
• Table 12 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Capsules, 2018 - 2033 (USD Million) (Kilotons)
• Table 13 U.S. Sustained Release Coatings Market Estimates And Forecasts, by Pills, 2018 - 2033 (USD Million) (Kilotons)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Primary Research Process
• Fig. 4 Market Research Approaches - Bottom-Up Approach
• Fig. 5 Market Research Approaches - Top-Down Approach
• Fig. 6 Market Research Approaches - Combined Approach
• Fig. 7 Market Snapshot
• Fig. 8 Segmental Outlook
• Fig. 9 Competitive Outlook
• Fig. 10 U.S. Sustained Release Coatings Market - Value Chain Analysis
• Fig. 11 U.S. Sustained Release Coatings Market - Sales Channel Analysis
• Fig. 12 Market Drivers Impact Analysis
• Fig. 13 Market Restraint Impact Analysis
• Fig. 14 Industry Analysis - PORTERS
• Fig. 15 Industry Analysis - PESTEL
• Fig. 16 Substrate: Key Takeaways
• Fig. 17 Substrate: Market Share, 2024 & 2033
• Fig. 18 Application: Key Takeaways
• Fig. 19 Application: Market Share, 2024 & 2033
• Fig. 20 Polymer Material: Key Takeaways
• Fig. 21 Polymer Material: Market Share, 2024 & 2033
• Fig. 22 Region, 2024 & 2030 (USD Million) (Kilotons)
• Fig. 23 Regional Marketplace: Key Takeaways
• Fig. 24 Competition Categorization
• Fig. 25 Company Market Positioning
• Fig. 26 Strategy Mapping, 2024

U.S. Sustained Release Coatings Market Summary

The U.S. sustained release coatings market size was estimated at USD 169.4 million in 2024 and is projected to reach USD 305.4 million by 2033, growing at a CAGR of 6.2% from 2025 to 2033. The market growth is primarily driven by the rising demand for advanced drug delivery systems that improve therapeutic efficacy and patient adherence, particularly in the treatment of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders.

The country's robust pharmaceutical R&D ecosystem, supported by significant investments from both innovator and generic drug manufacturers, fosters continuous development of sophisticated coating technologies. The market presents strong growth opportunities driven by the rising adoption of personalized and precision medicine, increasing demand for once-daily or long-acting formulations, and growing use of sustained release technologies in both branded lifecycle management and generics differentiation. Advancements in polymer science, such as the development of biodegradable, plant-based, and smart polymers, are opening new avenues for innovation in drug delivery.

Despite its maturity, the market faces challenges including high formulation development costs, complex regulatory compliance requirements, and the technical difficulty of achieving consistent drug release across diverse patient populations. The need for specialized manufacturing infrastructure and skilled expertise adds to the capital intensity of bringing sustained-release products to the market.

U.S. Sustained Release Coatings Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the U.S. sustained release coatings market report based on application, substrate, and polymer material.

• Application Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• In Vitro
• In Vivo
• Substrate Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• Tablets
• Capsules
• Pills
• Polymer Material Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
• Ethyl & Methyl Cellulose
• Polyvinyl & Cellulose Acetate
• Methacrylic Acid
• PEG
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Scope & Assumption
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Substrates & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. List of Data Substrates

Chapter 2. Executive Summary

• 2.1. Market Outlook, 2024 (USD Million) (Kilotons)
• 2.2. Segmental Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Sustained Release Coatings Market Variables, Trends & Scope

• 3.1. Market Lineage/Ancillary Market Outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Sales Channel Analysis
  • 3.2.2. Manufacturing Trends/Technological Advancements
  • 3.2.3. Raw Material Trends
• 3.3. Price Trend Analysis, 2018 - 2033
  • 3.3.1. Factors Influencing Prices
• 3.4. Regulatory Framework
  • 3.4.1. Analyst Perspective
  • 3.4.2. Regulations & Standards
• 3.5. Market Dynamics
  • 3.5.1. Market Driver Analysis
  • 3.5.2. Market Restraint Analysis
  • 3.5.3. Industry Opportunities
  • 3.5.4. Industry Challenges
• 3.6. Business Environmental Tools Analysis: U.S. Sustained Release Coatings Market
  • 3.6.1. Porter's Five Forces Analysis
    • 3.6.1.1. Bargaining Power of Suppliers
    • 3.6.1.2. Bargaining Power of Buyers
    • 3.6.1.3. Threat of Substitution
    • 3.6.1.4. Threat of New Entrants
    • 3.6.1.5. Competitive Rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political Landscape
    • 3.6.2.2. Economic Landscape
    • 3.6.2.3. Social Landscape
    • 3.6.2.4. Polymer Material Landscape
    • 3.6.2.5. Environmental Landscape
    • 3.6.2.6. Legal Landscape

Chapter 4. U.S. Sustained Release Coatings Market: Application Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Application Movement Analysis & Market Share, 2024 & 2033
  • 4.2.1. U.S. Sustained Release Coatings Market By Application, 2021 - 2033 (USD Million) (Kilotons)
• 4.3. In Vitro
  • 4.3.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for In Vitro, 2021 - 2033 (USD Million) (Kilotons)
• 4.4. In Vivo
  • 4.4.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for In Vivo, 2021 - 2033 (USD Million) (Kilotons)

Chapter 5. U.S. Sustained Release Coatings Market: Substrate Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Substrate Movement Analysis & Market Share, 2024 & 2033
• 5.3. U.S. Sustained Release Coatings Market By Substrate, 2021 - 2033 (USD Million) (Kilotons)
• 5.4. Tablets
  • 5.4.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Tablets, 2021 - 2033 (USD Million)
• 5.5. Capsules
  • 5.5.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Capsules, 2021 - 2033 (USD Million)
• 5.6. Pills
  • 5.6.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Pills, 2021 - 2033 (USD Million)

Chapter 6. U.S. Sustained Release Coatings Market: Polymer Material Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. Polymer Material Movement Analysis & Market Share, 2024 & 2033
• 6.3. U.S. Sustained Release Coatings Market By Polymer Material, 2021 - 2033 (USD Million) (Kilotons)
• 6.4. Ethyl & Methyl Cellulose
  • 6.4.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Ethyl & Methyl Cellulose, 2021-203 (USD Million)
• 6.5. Polyvinyl & Cellulose Acetate
  • 6.5.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Polyvinyl & Cellulose Acetate, 2021 - 2033 (USD Million)
• 6.6. Methacrylic Acid
  • 6.6.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Hot melt, 2021 - 2033 (USD Million)
• 6.7. PEG
  • 6.7.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for PEG, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. U.S. Sustained Release Coatings Market Estimates And Forecasts, for Others, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Key Players, their Recent Developments, and their Impact on Industry
• 7.2. Competition Categorization
• 7.3. Company Market Position Analysis
• 7.4. Company Heat Map Analysis
• 7.5. Strategy Mapping, 2024
• 7.6. Company Listing
  • 7.6.1. BASF SE
    • 7.6.1.1. Company Overview
    • 7.6.1.2. Financial Performance
    • 7.6.1.3. Product Type Benchmarking
    • 7.6.1.4. Strategic Initiatives
  • 7.6.2. Evonik
    • 7.6.2.1. Company Overview
    • 7.6.2.2. Financial Performance
    • 7.6.2.3. Product Type Benchmarking
    • 7.6.2.4. Strategic Initiatives
  • 7.6.3. Colorcon
    • 7.6.3.1. Company Overview
    • 7.6.3.2. Financial Performance
    • 7.6.3.3. Product Type Benchmarking
    • 7.6.3.4. Strategic Initiatives
  • 7.6.4. Coating Place, Inc.
    • 7.6.4.1. Company Overview
    • 7.6.4.2. Financial Performance
    • 7.6.4.3. Product Type Benchmarking
    • 7.6.4.4. Strategic Initiatives
  • 7.6.5. Teva Pharmaceutical Industries Ltd.
    • 7.6.5.1. Company Overview
    • 7.6.5.2. Financial Performance
    • 7.6.5.3. Product Type Benchmarking
    • 7.6.5.4. Strategic Initiatives
  • 7.6.6. Pfizer, Inc.
    • 7.6.6.1. Company Overview
    • 7.6.6.2. Financial Performance
    • 7.6.6.3. Product Type Benchmarking
    • 7.6.6.4. Strategic Initiatives
  • 7.6.7. Sun Pharmaceutical Industries Ltd.
    • 7.6.7.1. Company Overview
    • 7.6.7.2. Financial Performance
    • 7.6.7.3. Product Type Benchmarking
    • 7.6.7.4. Strategic Initiatives
  • 7.6.8. Novartis AG
    • 7.6.8.1. Company Overview
    • 7.6.8.2. Financial Performance
    • 7.6.8.3. Product Type Benchmarking
    • 7.6.8.4. Strategic Initiatives
  • 7.6.9. AstraZeneca
    • 7.6.9.1. Company Overview
    • 7.6.9.2. Financial Performance
    • 7.6.9.3. Product Type Benchmarking
    • 7.6.9.4. Strategic Initiatives
  • 7.6.10. GlaxoSmithKline plc
    • 7.6.10.1. Company Overview
    • 7.6.10.2. Financial Performance
    • 7.6.10.3. Product Type Benchmarking
    • 7.6.10.4. Strategic Initiatives
  • 7.6.11. AbbVie Inc.
    • 7.6.11.1. Company Overview
    • 7.6.11.2. Financial Performance
    • 7.6.11.3. Product Type Benchmarking
    • 7.6.11.4. Strategic Initiatives